Individualising therapy for drug-sensitive tuberculosis

Lancet Respir Med. 2019 Oct;7(10):834-835. doi: 10.1016/S2213-2600(19)30247-4. Epub 2019 Aug 16.

¹ Medical Research Council Clinical Trials Unit, University College London, London, UK; Institute for Global Health, University College London, London, UK; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: h.esmail@ucl.ac.uk.
² University College London Respiratory, Division of Medicine, University College London, London, UK.
³ Medical Research Council Clinical Trials Unit, University College London, London, UK.
⁴ Nuffield Department of Medicine, University of Oxford, Oxford, UK.

No abstract available

MeSH terms